1
|
Aldea D, Kokalari B, Atsuta Y, Dingwall HL, Zheng Y, Nace A, Cotsarelis G, Kamberov YG. Differential modularity of the mammalian Engrailed 1 enhancer network directs sweat gland development. PLoS Genet 2023; 19:e1010614. [PMID: 36745673 PMCID: PMC9934363 DOI: 10.1371/journal.pgen.1010614] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2022] [Revised: 02/16/2023] [Accepted: 01/13/2023] [Indexed: 02/07/2023] Open
Abstract
Enhancers are context-specific regulators of expression that drive biological complexity and variation through the redeployment of conserved genes. An example of this is the enhancer-mediated control of Engrailed 1 (EN1), a pleiotropic gene whose expression is required for the formation of mammalian eccrine sweat glands. We previously identified the En1 candidate enhancer (ECE) 18 cis-regulatory element that has been highly and repeatedly derived on the human lineage to potentiate ectodermal EN1 and induce our species' uniquely high eccrine gland density. Intriguingly, ECE18 quantitative activity is negligible outside of primates and ECE18 is not required for En1 regulation and eccrine gland formation in mice, raising the possibility that distinct enhancers have evolved to modulate the same trait. Here we report the identification of the ECE20 enhancer and show it has conserved functionality in mouse and human developing skin ectoderm. Unlike ECE18, knock-out of ECE20 in mice reduces ectodermal En1 and eccrine gland number. Notably, we find ECE20, but not ECE18, is also required for En1 expression in the embryonic mouse brain, demonstrating that ECE20 is a pleiotropic En1 enhancer. Finally, that ECE18 deletion does not potentiate the eccrine phenotype of ECE20 knock-out mice supports the secondary incorporation of ECE18 into the regulation of this trait in primates. Our findings reveal that the mammalian En1 regulatory machinery diversified to incorporate both shared and lineage-restricted enhancers to regulate the same phenotype, and also have implications for understanding the forces that shape the robustness and evolvability of developmental traits.
Collapse
Affiliation(s)
- Daniel Aldea
- Department of Genetics, Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America
| | - Blerina Kokalari
- Department of Genetics, Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America
| | - Yuji Atsuta
- Genetics Department, Harvard Medical School, Boston, Massachusetts, United States of America
| | - Heather L. Dingwall
- Department of Genetics, Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America
| | - Ying Zheng
- Department of Dermatology, Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America
| | - Arben Nace
- Department of Dermatology, Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America
| | - George Cotsarelis
- Department of Dermatology, Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America
| | - Yana G. Kamberov
- Department of Genetics, Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America
| |
Collapse
|
2
|
Design, synthesis, and biological activity of TLR7-based compounds for chemotherapy-induced alopecia. Invest New Drugs 2019; 38:79-91. [PMID: 31270708 DOI: 10.1007/s10637-019-00793-5] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2019] [Accepted: 05/13/2019] [Indexed: 10/26/2022]
Abstract
Hair loss is a common dermatosis symptom and side-effect in cancer chemotherapeutics. Imiquimod application at mid and late telogen activated the hair follicle stem cells leading to premature hair cycle entry. Based on quinoline structure, a newly synthesized compound 6b displayed proliferation activity in vitro and in vivo through branch chain replacement and triazole ring cyclization. Toll-like receptors (TLRs) are also critical mediators of the immune system, and their activation is linked to various diseases. The present study aimed to expand new agonists within co-crystallization of TLR7 (PDB code: 5GMH); however, biological assays of NF-κB activity and NO-inhibition indicated that five selected compounds were TLR7 antagonists. Molecular docking indicated the binding mode differences: antagonists binding TLR7 in a different direction and interacting with adjacent TLR7 with difficulty in forming dimers.
Collapse
|
3
|
Haensel D, Sun P, MacLean AL, Ma X, Zhou Y, Stemmler MP, Brabletz S, Berx G, Plikus MV, Nie Q, Brabletz T, Dai X. An Ovol2-Zeb1 transcriptional circuit regulates epithelial directional migration and proliferation. EMBO Rep 2018; 20:embr.201846273. [PMID: 30413481 DOI: 10.15252/embr.201846273] [Citation(s) in RCA: 27] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2018] [Revised: 10/08/2018] [Accepted: 10/12/2018] [Indexed: 01/06/2023] Open
Abstract
Directional migration is inherently important for epithelial tissue regeneration and repair, but how it is precisely controlled and coordinated with cell proliferation is unclear. Here, we report that Ovol2, a transcriptional repressor that inhibits epithelial-to-mesenchymal transition (EMT), plays a crucial role in adult skin epithelial regeneration and repair. Ovol2-deficient mice show compromised wound healing characterized by aberrant epidermal cell migration and proliferation, as well as delayed anagen progression characterized by defects in hair follicle matrix cell proliferation and subsequent differentiation. Epidermal keratinocytes and bulge hair follicle stem cells (Bu-HFSCs) lacking Ovol2 fail to expand in culture and display molecular alterations consistent with enhanced EMT and reduced proliferation. Live imaging of wound explants and Bu-HFSCs reveals increased migration speed but reduced directionality, and post-mitotic cell cycle arrest. Remarkably, simultaneous deletion of Zeb1 encoding an EMT-promoting factor restores directional migration to Ovol2-deficient Bu-HFSCs. Taken together, our findings highlight the important function of an Ovol2-Zeb1 EMT-regulatory circuit in controlling the directional migration of epithelial stem and progenitor cells to facilitate adult skin epithelial regeneration and repair.
Collapse
Affiliation(s)
- Daniel Haensel
- Department of Biological Chemistry, School of Medicine, University of California, Irvine, CA, USA
| | - Peng Sun
- Department of Biological Chemistry, School of Medicine, University of California, Irvine, CA, USA
| | - Adam L MacLean
- Department of Mathematics, University of California, Irvine, CA, USA
| | - Xianghui Ma
- Department of Biological Chemistry, School of Medicine, University of California, Irvine, CA, USA
| | - Yuan Zhou
- Department of Biological Chemistry, School of Medicine, University of California, Irvine, CA, USA
| | - Marc P Stemmler
- Department of Experimental Medicine, Nikolaus-Fiebiger-Center for Molecular Medicine, Friedrich-Alexander University Erlangen-Nuernberg, Erlangen, Germany
| | - Simone Brabletz
- Department of Experimental Medicine, Nikolaus-Fiebiger-Center for Molecular Medicine, Friedrich-Alexander University Erlangen-Nuernberg, Erlangen, Germany
| | - Geert Berx
- Molecular and Cellular Oncology Lab, Department of Biomedical Molecular Biology, Ghent University, Zwijnaarde, Belgium.,Cancer Research Institute Ghent (CRIG), Ghent, Belgium
| | - Maksim V Plikus
- Department of Developmental and Cell Biology, University of California, Irvine, CA, USA
| | - Qing Nie
- Department of Mathematics, University of California, Irvine, CA, USA.,Department of Developmental and Cell Biology, University of California, Irvine, CA, USA
| | - Thomas Brabletz
- Department of Experimental Medicine, Nikolaus-Fiebiger-Center for Molecular Medicine, Friedrich-Alexander University Erlangen-Nuernberg, Erlangen, Germany
| | - Xing Dai
- Department of Biological Chemistry, School of Medicine, University of California, Irvine, CA, USA
| |
Collapse
|